Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 9.9B | 1.8B | 14.0B | 7.4B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.2B | 2.6B | 1.8B | 2.2B |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 133M | 182M | 185M | 138M |
Other income expense | — | — | — | — |
Pretax income | 1.2B | 589M | 1.6B | 910M |
Tax provision | 242M | 372M | 215M | 192M |
Net income | 1.0B | 217M | 1.4B | 718M |
Basic EPS | 1.6 | — | 2.3 | 1.1 |
Diluted EPS | 1.6 | — | 2.3 | 1.1 |
Basic average shares | 572M | — | 578M | 581M |
Diluted average shares | 575M | — | 581M | 584M |
EBITDA | — | — | — | — |
Net income from continuing op. | 1.2B | 589M | 1.6B | 910M |
Minority interests | -6M | -75M | -6M | -4M |
Preferred stock dividends | 53M | -115M | 54M | 48M |